AMCR vs VTGN · P/E 18, rev $23.51B vs rev $1.3M
Amcor PLC (AMCR) versus VistaGen Therapeutics Inc (VTGN) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported VTGN revenue for 2026-03-31 was $1.3M. Net income was -$69.7M. Revenue was up 161.1% from 2025-03-31 to 2026-03-31. VTGN currently screens at market cap $28.1M.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. VTGN currently screens at market cap $28.1M.
Not investment advice. Open the AMCR and VTGN stock pages for the full models.
Not investment advice.